Marina Orlandini

Ms. Marina Orlandini

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2021 in Diseases of the Esophagus
Verified
Journal Article
Closed access
PDF file
MOMarina Orlandini
Marina Orlandini
MSMaria Carolina Andrade Serafim
Maria Carolina Andrade Serafim
LDLetícia Nogueira Datrino
Letícia Nogueira Datrino
GTGuilherme Tavares
Guilherme Tavares
LTLuca Schiliró Tristão
Luca Schiliró Tristão
Francisco TustumiFrancisco Tustumi
Francisco Tustumi
Introduction: Achalasia may evolve to sigmoid megaesophagus in 10–15% of patients and is usually treated with esophagectomy, which has high morbi-mortality. Many surgeons debate the applicability of the Heller myotomy for treating sigmoid megaesophagus. This study intents to analyze the effectiveness of myotomy for treating patients with sigmoid megaesophagus. Methods: A systematic review and meta-analysis was conducted in PubMed, Cochrane, Lilacs and Embase alongside manual search of references. The inclusion criteria were clinical trials, cohort, case-series; patients with sigmoid megaesophagus and esophageal diameter ≥ 6 cm; and patients undergoing primary myotomy. The exclusion criteria were reviews, case reports, cross-sectional studies, editorials, letters, congress abstracts, full-text unavailability; previous surgical treatment for achalasia; and pediatric or animal model studies. No restrictions on language and date of publication, and no filters were applied. Subgroups analyses were performed to assess the laparoscopic myotomy perioperative outcomes. Besides, subgroup analyses were performed to assess the long-term outcomes of the studies with a follow-up time > 24 months. To verify heterogeneity, the I2 test was used. The random effects were applied, and the fixed model was evaluated as sensitivity analysis. To assess risk of bias and certainty of evidence, the tools ROBINS-I and GRADE were used, respectively. Registration number: CRD42020199667. Results: Sixteen articles were selected, encompassing 350 patients. The mean age ranged from 36 to 61 years old, and the mean follow-up ranged from 16 to 109 months. Complications rate was 0.08 (CI: 0.040–0.153; P = 0.01). Need for retreatment rate was 0.128 (CI: 0.031–0.409; P = 0.01). The probability of good or excellent outcomes after myotomy was 0.762 (CI: 0.703–0.812; P < 0.01). Postoperative mortality rate was 0.008 (CI: 0.004–0.015; P < 0.01). Conclusion: Surgical myotomy is an option for avoiding esophagectomy in achalasia, with a low morbi-mortality rate and good results. It is effective for most patients and only a minority will demand retreatment.

11 June 2022 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
LDLetícia Nogueira Datrino
Letícia Nogueira Datrino
MOMarina Orlandini
Marina Orlandini
MSMaria Carolina Andrade Serafim
Maria Carolina Andrade Serafim
CSClara Lucato dos Santos
Clara Lucato dos Santos
VMVictoria Andrade Modesto
Victoria Andrade Modesto
Francisco TustumiFrancisco Tustumi
Francisco Tustumi

12 January 2023 in Economies
Verified
Journal Article
Open access
PDF file
Patricia Véras MarronePatricia Véras Marrone
Patricia Véras Marrone
FMFabio Rampazzo Mathias
Fabio Rampazzo Mathias
WBWanderley Bernardo
Wanderley Bernardo
MOMarina Orlandini
Marina Orlandini
MSMaria Carolina Andrade Serafim
Maria Carolina Andrade Serafim
EDEduardo Mario Dias
Eduardo Mario Dias
(1) Background: Any disturbance in the pharmaceutical supply chain (PSC) can disrupt the supply of medicines and affect the efficiency of health systems. Due to shortages in the global pharma supply chain over the past few years and the complex nature of free trade and its limitations when confronted by a major global health and humanitarian crisis, many countries have taken steps to mitigate the risks of disruption, including, for example, recommending the adoption of a plus one diversification approach, increasing safety stock, and nationalizing the medical supply chains. (2) Objective: To scope findings in the academic literature related to decision criteria to guide national policy decisions for the “Partial Nationalization of Pharmaceutical Supply Chain” (PNPSC) from the viewpoints of the three main stakeholders: industry, payers (government and health insurance), and patients. (3) Methods: These consist of a scoping review of the peer-reviewed literature. (4) Results: A total of 115 studies were included. For local manufacturing decisions, five criteria and 15 sub-criteria were identified. Weighting, decision-making, risk assessment, and forecasting were the main data analysis tools applied; (5) Conclusions: The findings could serve as a baseline for constructing PNPSC frameworks after careful adaptation to the local context.

1 January 2021 in Revista do Colégio Brasileiro de Cirurgiões
Verified
Journal Article
Open access
PDF file
MOMarina Orlandini
Marina Orlandini
WBWanderley Marques Bernardo
Wanderley Marques Bernardo
Francisco TustumiFrancisco Tustumi
Francisco Tustumi